Unknown

Dataset Information

State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2.


ABSTRACT:

Introduction

The SARS-CoV-2 (previously 2019-nCoV) outbreak in Wuhan, China and other parts of the world affects people and spreads coronavirus disease 2019 (COVID-19) through human-to-human contact, with a mortality rate of > 2%. There are no approved drugs or vaccines yet available against SARS-CoV-2.

Material and methods

State-of-the-art tools based on in-silico methods are a cost-effective initial approach for identifying appropriate ligands against SARS-CoV-2. The present study developed the 3D structure of the envelope and nucleocapsid phosphoprotein of SARS-CoV-2, and molecular docking analysis was done against various ligands.

Results

The highest log octanol/water partition coefficient, high number of hydrogen bond donors and acceptors, lowest non-bonded inter

SUBMITTER: Azeez SA 

PROVIDER: S-EPMC7212236 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature